Hochschulschrift
New approaches to improve prediction of drug-induced liver injury
- Weitere Titel
-
Neue Ansätze zur verbesserten Vorhersage arzneimittelinduzierter Leberschäden
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Diss., 2012
- Schlagwort
-
Biomarker ; Leber ; Lebertoxizität
Arzneimittelentwicklung
Arzneimitteldesign
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universitätsbibliothek der Universität Würzburg
- (wann)
-
2012
- Urheber
-
Adler, Melanie
- Beteiligte Personen und Organisationen
-
Mally, Angela
- URN
-
urn:nbn:de:bvb:20-opus-69512
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Adler, Melanie
- Mally, Angela
- Universitätsbibliothek der Universität Würzburg
Entstanden
- 2012
Ähnliche Objekte (12)
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Improved early in vitro prediction of drug-induced liver injury in man: assessment of novel 3D hepatic models
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Improved early in vitro prediction of drug-induced liver injury in man: assessment of novel 3D hepatic models
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Improved early in vitro prediction of drug-induced liver injury in man: assessment of novel 3D hepatic models
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?